Browsing by Author "Arsikj, Elena (58078722500)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future †(2023) ;Gokengin, Deniz (6603234930) ;Bursa, Dominik (57194389543) ;Skrzat-Klapaczynska, Agata (57200220975) ;Alexiev, Ivailo (24400977400) ;Arsikj, Elena (58078722500) ;Balayan, Tatevik (56049390500) ;Begovac, Josip (7004168039) ;Cicic, Alma (57191286606) ;Dragovic, Gordana (23396934400) ;Harxhi, Arjan (8690048500) ;Aimla, Kerstin (57908888600) ;Lakatos, Botond (36614563800) ;Matulionyte, Raimonda (12239067500) ;Mulabdic, Velida (30067838900) ;Oprea, Cristiana (21636591500) ;Papadopoulos, Antonios (7101944704) ;Rukhadze, Nino (54883291900) ;Sedlacek, Dalibor (57202125317) ;Sojak, Lubomir (57218826535) ;Tomazic, Janez (6603749556) ;Vassilenko, Anna (57194138824) ;Vasylyev, Marta (57200106670) ;Verhaz, Antonija (6507063101) ;Yancheva, Nina (36910505000) ;Yurin, Oleg (6603122381)Kowalska, Justyna (35105197800)With no expected vaccine for HIV in the near future, we aimed to define the current situation and challenges for pre- and post-exposure prophylaxis (PrEP and PEP) in Central and Eastern Europe (CEE). The Euroguidelines CEE Network Group members were invited to respond to a 27-item survey including questions on PrEP (response rate 91.6%). PrEP was licensed in 68.2%; 95 centers offered PrEP and the estimated number on PrEP was around 9000. It was available in daily (40.1%), on-demand (13.3%), or both forms (33.3%). The access rate was <1–80%. Three major barriers for access were lack of knowledge/awareness among people who are in need (59.1%), not being reimbursed (50.0%), and low perception of HIV risk (45.5%). Non-occupational PEP was available in 86.4% and was recommended in the guidelines in 54.5%. It was fully reimbursed in 36.4%, only for accidental exposures in 40.9%, and was not reimbursed in 22.72%. Occupational PEP was available in 95.5% and was reimbursed fully. Although PrEP scale-up in the region has gained momentum, a huge gap exists between those who are in need of and those who can access PrEP. Prompt action is required to address the urgent need for PrEP scale-up in the CEE region. © 2023 by the authors. - Some of the metrics are blocked by yourconsent settings
Publication PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future †(2023) ;Gokengin, Deniz (6603234930) ;Bursa, Dominik (57194389543) ;Skrzat-Klapaczynska, Agata (57200220975) ;Alexiev, Ivailo (24400977400) ;Arsikj, Elena (58078722500) ;Balayan, Tatevik (56049390500) ;Begovac, Josip (7004168039) ;Cicic, Alma (57191286606) ;Dragovic, Gordana (23396934400) ;Harxhi, Arjan (8690048500) ;Aimla, Kerstin (57908888600) ;Lakatos, Botond (36614563800) ;Matulionyte, Raimonda (12239067500) ;Mulabdic, Velida (30067838900) ;Oprea, Cristiana (21636591500) ;Papadopoulos, Antonios (7101944704) ;Rukhadze, Nino (54883291900) ;Sedlacek, Dalibor (57202125317) ;Sojak, Lubomir (57218826535) ;Tomazic, Janez (6603749556) ;Vassilenko, Anna (57194138824) ;Vasylyev, Marta (57200106670) ;Verhaz, Antonija (6507063101) ;Yancheva, Nina (36910505000) ;Yurin, Oleg (6603122381)Kowalska, Justyna (35105197800)With no expected vaccine for HIV in the near future, we aimed to define the current situation and challenges for pre- and post-exposure prophylaxis (PrEP and PEP) in Central and Eastern Europe (CEE). The Euroguidelines CEE Network Group members were invited to respond to a 27-item survey including questions on PrEP (response rate 91.6%). PrEP was licensed in 68.2%; 95 centers offered PrEP and the estimated number on PrEP was around 9000. It was available in daily (40.1%), on-demand (13.3%), or both forms (33.3%). The access rate was <1–80%. Three major barriers for access were lack of knowledge/awareness among people who are in need (59.1%), not being reimbursed (50.0%), and low perception of HIV risk (45.5%). Non-occupational PEP was available in 86.4% and was recommended in the guidelines in 54.5%. It was fully reimbursed in 36.4%, only for accidental exposures in 40.9%, and was not reimbursed in 22.72%. Occupational PEP was available in 95.5% and was reimbursed fully. Although PrEP scale-up in the region has gained momentum, a huge gap exists between those who are in need of and those who can access PrEP. Prompt action is required to address the urgent need for PrEP scale-up in the CEE region. © 2023 by the authors.
